Trials / Completed
CompletedNCT02191020
Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis
Multi-center, Randomized, Double Blind, Placebo Parallel-Controlled Study of the Efficacy and Safety of Total Glucosides of Paeony Combined With Acitretin Capsules to Treat Psoriasis Vulgaris
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double blind, placebo parallel-controlled, multi-center clinical trial. Patients with psoriasis vulgaris were randomly divided into the experiment group (treated with TGP combined with acitretin capsules) and control group (treated with placebo combined with acitretin capsules).The treatment lasted 12 weeks. The efficacy and safety were evaluated at the baseline, as well as 2, 4, 8 and 12 weeks after the beginning of treatment.The investigator's hypothesis TGP combined with Acitretin Capsulesin is more safe and effective than Acitretin Capsulesin to treat Psoriasis Vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Total glucosides of paeony & Acitretin Capsules | |
| DRUG | Acitretin Capsules |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2014-07-15
- Last updated
- 2014-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02191020. Inclusion in this directory is not an endorsement.